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Oxygen is vital for aerobic processes of metabolism and respiration- It has been also implicated in many diseases and 
degenerative conditions. Free radicals formed from reactive oxygen and nitrogen species act as key players in the initiation 
and progression of tumor cells and enhance their metastatic potential. The imbalance in the formation and use of free 
radicals in the tissue creates oxidative stress. Inadequacy in normal cells antioxidant defense system or excessive free radical 
formation or even both can cause the cell to experience the oxidative stress. This review outlines the involvement of free 
radicals in different aspects of cancer, from prevention to initiation, progression, treatment and to reduce morbidity and 
mortality.  
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Introduction 
Human life on earth is possible due to the presence 
of oxygen which is essential for cellular activities. 
Out of the total inhaled oxygen around 5% is 
converted to Reactive Oxygen Species (ROS) by the 
univalent reduction of oxygen. This poisonous 
property of O2 is disclosed by the Gershman‘s free 
radical theory of oxygen toxicity in 1954. According 
to this theory the oxygen toxicity is due to incomplete 
reduction of oxygen. It reveals the dual role of ROS 
and RNS (Reactive Nitrogen Species). Further, it 
clarifies that ROS and RNS have both beneficial and 




At the low and moderate concentrations, ROS 
shows beneficial effect by participating in the 
physiological mechanisms, Such as cellular defense 
against infectious agents, cellular signaling, induction 
of mutagenic response, electron transport chain, etc. 
On the other hand, the free radicals at high 
concentration, show deleterious effect due to 
imbalance between the production of free radicals and 
cellular antioxidants which creates oxidative stress
3
. 
In the biological systems, oxidative stress is due to the 
excess production of ROS/RNS as well as deficiency 
of enzymatic and non-enzymatic antioxidant. The 
redox regulation mechanism of the living organisms 
creates the equilibrium between the beneficial and 
deleterious effect of the free radicals which is 
essential for the survival. This redox regulation 
mechanism forms a redox homeostasis, protects living 
organisms from various oxidative stress by managing 
the redox status in vivo
4
. This review deals with  
(i) The mechanism of formation of free radicals  
in respiring cells under aerobic conditions;  
(ii) The antioxidant systems involved in the 
scavenging process; (iii) Free radicals mediated 
damage to the cellular macromolecules (Lipids, 
Proteins, and DNA); (iv) The involvement of free 
radicals in different aspects of Cancer, from 
prevention to initiation, progression, treatment, and 
recovery; and (v) Controversial views of antioxidants 
in cancer therapy. 
 
Free radicals 
Free radicals are highly unstable, and reactive with 
short half-lives. Their hyper reactivity is due to the 
presence of one or more unpaired electrons in its 
outermost shell of their atoms. These unpaired 
electrons try to attain balance by binding with 
electrons of neighbouring atoms, giving rise to chain 
reactions
5
. Free radicals are produced from oxygen 








of tasks such as signaling, metabolizing xenobiotic, 
initiating apoptosis, stimulation of antioxidants, repair 
process. Hence, its production in an animal cell is 
inevitable
6
. Increase in free radical level leads to 
oxidative stress. Increased number of free radicals, in 
turn steals number of electrons from neighbouring, 
DNA, enzymes and cell membranes which affect their 
structure and composition, leads to cell damage. Free 
radicals are not only the byproducts of cellular 
processes but also introduced into our bodies 
exogenously by cigarette smoking, radiation, drinking 
alcohol, air and water pollution, certain gases and even 
sunlight. The major forms of free radicals present in 
our body are hydroxyl radicals and superoxides. 
Hydroxyl free radicals are necessary for 
hydroxylation of lysine and proline amino acids to 
hydroxylysine and hydroxyproline, respectively, it is 
also necessary for collagen biosynthesis
7
. Defense 
mechanism against bacteria and virus, via 
macrophages and leucocytes, also contribute to the 
formation of free radicals. For normal metabolism  
of cell free radicals are needed, However, the 
presence of free radicals poses a risk of damage for 




The mitochondrion is the major site of the 
superoxide free radical (O2
-•) by the action of 
NADPH (Nicotinamide Adenine Dinucleotide 
Phosphate) oxidase enzyme
11
. In dismutation, the 
reactive hydrogen peroxide (H2O2) is formed by the 
action of superoxide dismutase (SOD). It happens 
when the superoxide radical reacts with itself and 
forms oxygen and hydrogen peroxide
6
. Continuous 
reduction process transforms the hydrogen peroxide 
via the Fenton reaction into the hydroxyl free radical 
(•OH) which is highly reactive, and finally, water is 
formed, mediated by the action of catalase (CAT) or 
glutathione peroxidase (GPx)
6,12
. In some cases, 
oxygen molecule binds to a proton, another free 
radical is formed known as the hydro peroxide radical 
(HO2 −•)
13
. Figure 1 depicts different reactive forms 
of oxygen
6,14,15 
The free radicals in Reactive Nitrogen  
Species (RNS) are nitric oxide (NO•), peroxynitrite 
(ONOO–), nitrogendioxide (NO2•) and nitrite (NO2−). 
NO• is synthesized from a guanidine group of  
L-arginine by an enzyme of the nitric oxide 
synthetase (NOS) family. The formation of ONOO− 
takes place by the reaction of NO• with a molecule of 
O2−•, which forms nitrogen dioxide (NO2•) as an 
intermediary. This intermediary reacts with NO• to 
finally generate anhydride nitrous (N2O3)
13,15,16
. 
The isoforms of NOS are neuronal (nNOS or 
NOSI), inducible (iNOS or NOSII), endothelial 
(eNOS or NOSIII) and mitochondrial (mtNOS). All 
these forms dependent on NADPH and calmodulin
17
. 
eNOS has a remarkable role in tumor development, as 
it modulates various tumor-related processes, such as 
apoptosis, angiogenesis, cell cycle, invasion, and 
metastasis
18. Different biological actions of NO• are 
mediated by guanylcyclase (sGC) and cyclic 
guanosine monophosphate (cGMP). NO• spreads to 
nearby cells and readily enters the cytosol, where it 
activates sGC by binding to the ―hem‖ component of 
iron on the porphyrin ring. As the concentration 
increases, its cytotoxic effects get activated which 
leads to inhibition of mitochondrial enzymes, 
including succinate, ubiquinone oxidoreductase, and 





Antioxidants are molecules which protect the body 
from damage caused by excess free radicals. 
Antioxidants neutralize these free radicals by sharing 
their extra electrons- so that they don‘t steal extra 
electrons from other vital organs of the cell. Free 
radical exposure of any organism leads to the 
development of defense mechanism in their body
20
. 
As per the nature of an antioxidant molecule, it is 
mainly divided into two categories, Enzymatic and 
Non enzymatic antioxidants. Enzymatic antioxidant 
defense includes superoxide dismutase (SOD), 
glutathione peroxidase (GPx), catalase (CAT).  
Non-enzymatic antioxidants are mainly vitamin C 
(ascorbic acid), vitamin E (α-tocopherol), vitamin A 
(β carotene), and glutathione (GSH), flavonoids. 
There is a balance between both free radicals and the 
level of the antioxidants in the body under normal 
conditions. For the survival of the organism and its 
health, this balance is essential. 
 
 
Fig. 1 — The different reactive forms of oxygen and antioxidants 
 




Glutathione disulphide (GSSG) is the oxidized 
form of glutathione. Glutathione is the major soluble 
antioxidant in cell compartments
21
. It is highly 
abundant in the cytosol (1-11 mM), nuclei  
(3-15 mM), and mitochondria (5-11 mM). GSH is 
synthesized in the cytosol by the sequential action of 
glutamate–cysteine ligase and glutathione synthetase. 
Its mitochondrial presence requires inner membrane 
transport. The dicarboxylate carrier protein and the  
2- oxoglutarate carrier protein are the two 
mitochondrial electro neutral antiport carrier proteins 
shows the capacity to transport GSH.  
Studies points that, externally added GSH is  
readily taken up against the concentration gradient 
by mitochondria, despite the ∼8 mM GSH presents  
in the mitochondrial matrix
22
. The redox state  
of critical protein sulfhydryl‘s which are necessary  
for DNA repair and expression is maintained by  
GSH in the nucleus. Studies concluded that  
oxidized glutathione is accumulated inside the cells 
and the ratio of GSH/GSSG is a good measure  
of oxidative stress of an organism
23,24
. A high 
concentration of GSSG may damage many enzymes 
oxidatively. 
The different protective roles of glutathione against 
oxidative stress are: 
(i) It acts as a cofactor for many detoxifying 
enzymes against oxidative stress, e.g. Glutathione 
transferase, Glutathione peroxidase and others. 
(ii) Through plasma membrane, GSH participates in 
amino acid transport. 
(iii) It directly scavenges hydroxyl radicals and singlet 
oxygen while catalytic actions of glutathione 
peroxidase detoxify hydrogen peroxide and lipid 
peroxidases. 
(iv) GSH has the ability to regenerate antioxidants and 
return to their active forms, like reduction of 




The ability of glutathione to regenerate  
the antioxidant is associated with the redox  
state of glutathione disulphide-glutathione couple 
(GSSG/2GSH). Multiple roles of enzymatic and  
non-enzymatic antioxidants in rescue against 




Free radicals mediated damage to the cellular 
macromolecules 
The essential cell components like lipids, proteins 
and nucleic acids are under the threat of high 
concentrations of free radicals
2
. These free radicals 
can alter intrinsic membrane properties like fluidity, 
ion transport, loss of enzyme activity, protein  
cross-linking, and inhibition of protein synthesis. All 
components of the DNA molecule are under the threat 
of hydroxyl radicals, damaging both the purine  
and pyrimidine bases and also the deoxy-ribose backbone, 




Lipid peroxidation  
The oxidative modifications of lipids are catalase 
by reactive oxygen species
43
. The hydrogen becomes 
more prone to abstraction in the presence of a double 
bond adjacent to a methylene group makes the  
C-H bond of polysaturated fatty acid (PUFA) weaker. 
Lipid peroxidation is initiated by OH•, alkoxy radicals 
(RO•), and peroxy radicals (ROO•), not by the  
O2− and H2O2
44
. Peroxy radicals act as both reaction 
initiators as well as the products of lipid peroxidation, 
leads to a self-perpetuating process. Oxidation of the 
substrate is possible by the transfer of electrons when 
lipid peroxy radicals react with other lipids, proteins, 
and nucleic acids. Cell membranes, undergoes 
changes in membrane fluidity, permeability, and 
cellular metabolic functions during oxidative 
attackdue to the presence of large amount of PUFA. 
The crucial aldehyde products of lipid peroxidation 
aremalondialdehyde (MDA) and 4-hydroxy-2-nonenal 
(HNE). In bacterial and mammalian cells MDA  
is mutagenic and in rats it is carcinogenic. The  
major toxic product of lipid peroxidation is 





Reactive Oxygen Species may induce oxidative 
damage to DNA, both nuclear and mitochondrial.  
The major types of damages observed are base 
modifications, deoxyribose oxidation, strand breakage, 
and DNA-protein cross-links. Out of all the ROS, 
hydroxyl radicals produce many products from the 
DNA base which mainly include C-8 hydroxylation  
of guanine to form 8-oxo-7, 8 dehydro-2¢- 
deoxyguanosine, a ring-opened product; 2, 6-diamino-4-
hydroxy-5-formamimodipyrimidine, 8-OH-adenine,  
2-OH-adenine, thymine glycol, cytosine glycol, etc
50
. 
ROS also cause different mutagenic alterations in 
DNA. The most widely studied DNA lesion is the 
formation of 8-OH-G. Permanent modification of 
genetic material resulting from these ―oxidative 
damage‖ incidents represents the first step involved in 
mutagenesis, carcinogenesis and ageing. Mutations 




originating from selective modification of G:C sites 
indicates an oxidative attack on DNA by ROS. The 
action of 8-oxodeoxy-guanosine as a promutagen in 
altering the binding of methylase to the oligomer so as 
to inhibit methylation of adjacent cytosine has been 
reported in cases of cancer development
51,52
. 
ROS has shown activate mutations in human  
C-Ha-ras-1 proto-oncogene and induce mutation in 
the p53 tumor-suppressor gene
53
. It also interferes 
with normal cell signaling, resulting in alteration of 
the gene expression and development of cancer by 
redox regulation of transcriptional factors/activator 
and/or by oxidatively modulating the protein kinase 
cascades. Early response or stress-response  
genes like c-fos, c-jun, jun-B, jun-D, cmyc,  
erg-1, andhemeoxygenase-1are also produced by 
various ROS. A vital role is played bytheearly  
responseproto-oncogenes in signal transduction, 
leading to cell proliferation and transformation
54
. 
Abnormal components of the electron transport chain 
are formed by the oxidative damage of mitochondrial 
DNA which involves base modifications and strand 
break. This leads to the formation of more ROS 
through increased leakage of electrons and further cell 




Oxidative damage of proteins 
In the mitochondrial electron transport chain, free 
radicals are produced which can initiate protein 
degradation. Oxidative protein damage may be brought 
about by metabolic processes which degrade a 
damaged protein to promote synthesis of a new protein. 
On the basis of further studies on aging processes, it 
has been found out that, catalytically inactive or less 
active, more thermo labile forms of enzyme 
accumulate in cells during aging and show a noticeable 
increase in the level of protein carbonyl content which 
is an index of metal-catalyzed oxidation of proteins
56-58
. 
Studies in which amino acids, simple peptides, and 
proteins were exposed to ionizing radiations under 
conditions where hydroxyl radicals or a mixture of 
hydroxyl/superoxide radicals are formed describes the 
mechanisms involved in the oxidation of proteins by 
ROS
59
. By the action of ROS/RNS, the side chains of 
all amino acid residues particularly cysteine and 
methionine residues of proteins are susceptible to 
oxidation
59
. Oxidation of cysteine residues may lead to 
the reversible formation of mixed disulphides between 
protein thiolgroups (–SH) and low molecular  
weight thiols, in particular GSH (S-glutathionylation). 
The amount of carbonyl groups, generated by  
many different mechanisms is a good measure of  
ROS-mediated protein oxidation. Numerous highly 




Levels of glyceraldehyde-3-P-dehydrogenase, 
aspartate aminotransferase, and phosphoglycerate 
kinase decline with age together with an increase in 
protein carbonyl content in human erythrocytes
62
. The 
carbonyl content of protein in rat hepatocytes also 
elevated with age along with a decline in the activities 
of glutamine synthetase and glucose-6-P-dehydrogenase, 
without any loss in the total enzyme protein
63
. An  
age-related oxidative modification of human 
ceruloplasmin, a copper-containing protein in human 
plasma has also been reported
64
. The mechanism of 
oxidative damage of proteins by ROS has been studied 
in vitro by different ways, generating these reactive 
species in solution which is non-specific (global) 
damage, or ‗site-specifically‘ within the protein 
(localized) damage
65
. Non-specific damage can be 
formed by generating activated oxygen species in situ, 
using either a radiation source (Co
60
)- or using pulse 
radiolysis techniques; which lead to aggregation and 
fragmentation of the protein and modification of almost 
all the amino acid residues
66
. On the other hand, 
localized or ‗site-specific‘ damage, (which was 
extensively studied using glutamine synthetase as the 
model enzyme
65-68
) can occur when the ROS, such as 
•OH, are formed at putative metal-binding sites in 
proteins. When these sites are occupied by iron or 
copper, they can (in the presence of suitable reductants, 
O2 – or ascorbate) react with H2O2 to generate highly 
reactive •OH which reacts preferably with specific 
amino acids present in the vicinity of the metal-binding 
site
58,69
, thereby inducing specific damage (site-
specific) that shows no gross structural modification. 
The concept of ‗site-specificity‘ has been studied in 
detail by Halliwell, Gutteridge, and Stadtman
65,68
. It 
means that (i) catalytic metal ions, such as iron or 
copper would be bound to the target molecule (protein, 
DNA, or cell membrane), and the •OH produced by 
O2− (or ascorbate) and H2O2 produced at the ironor 
copperbinding site would then react preferentially with 
the target molecule; (ii) the damaging effect of •OH is 
observed at a specific site where catalytic ions are 
bound; and (iii) the defensive action of the freeradical 
scavengers to remove •OH from the specific site 
decreases dramatically, since they are unable to  
access the microenvironment. Although tryptophan, 




phenylalanine, and tyrosine residues of proteins are not 
the major sites of oxidation (as in the case of global 
damage) by the site-specific oxidative system; arginine, 
lysine, histidine, cysteine and proline are particularly 





Involvement of free radicals in different aspects of 
cancer 
The studies reveal that free radicals induced 
oxidative stress is closely related to all aspects of 
cancer, from prevention, initiation, progression, 
treatment, and recovery. The human body is 
constantly under oxidative stress arising from both 
endogenous and exogenous origin. When such 
oxidative stress exceeds the capacity of the body 
system to maintain oxidation-reduction homeostasis, 
gene mutation may result, affecting the intracellular 
signal transduction and transcription factors directly 
or via antioxidants, leading to carcinogenesis.  
 
In cancer prevention 
The cellular mechanism of defense against the 
consequences of increased concentrations of reactive 
species (mainly ROS) is by antioxidants
71
. Proofs for 
prevention of carcinogenesis and increased life span 
by the antioxidant supplementation is documented by 
Kovacic and Jacintho in 2001
72
. For a correct cellular 
response, the concentration of antioxidant 
supplementation is very important, as a low 
concentration may have no effect while a high 
concentration causes a negative effect and act as  
pro-oxidant or the free radical
73
. Oxidative stress 
leads to the over production of free radicals in the 
body which increases the chances for tumor initiation. 
Maintaining a proper equilibrium between free 
radicals and antioxidants prevent the body from all 
types of carcinomas. By donating their extra electrons 
antioxidant enzymes like SOD, Catalase and 
Glutathione peroxidase prevent oxidation and reduce 
the rate of chain initiation.They can also prevent 
oxidation by stabilizing transition metal radicals such 
as copper and iron
74,75
. The intake of dietary 
antioxidants like vitamins E, C, and β-carotene is 
useful in preventing carcinogenesis
76
. Different 
studies revealed that antioxidants can be used in the 
inhibition of inflammation in relation to the risk of 
carcinogenesis
77
. The risk of formation of pro-oxidant 
is always associated with excess supplementation of 
antioxidants, for example, vitamin C
78
. The type of 
antioxidant and its amount to be ingested for 
obtaining a preventive effect in cancer remains under 
investigation. 
 
In cancer initiation 
Due to the presence of free radicals, cancer cells 
compared with normal cells forms a cellular redox 
imbalance, this redox imbalance thus related to 
oncogenic stimulation.The first step involved in 
mutagenesis, carcinogenesis, and ageing is ―Oxidative 
damage‖ from free radicals resulting from the 
permanent modification of genetic material. In various 
tumors DNA mutation is a crucial step and elevated 
levels of oxidative DNA lesions have been noticed, 
which strongly implicating such damage in the etiology 
of cancer. More than 100 oxidized DNA products have 
been identified. Free radical based DNA damage 
includes single or double-stranded DNA breaks, 
purine, pyrimidine, or deoxyribose modifications, and 
DNA crosslinks. DNA damage may end up with arrest 
or induction of transcription, transduction pathways, 
replication errors and genomic instability, all of  
which are associated with carcinogenesis
2,79
, 8-OH-
Gformation is the most extensively studied DNA 
lesion. It is a potential biomarker of carcinogenesis as it 
is relatively easily formed and is mutagenic. DNA 
damage, mutations, and altered gene expressions, all 
are having a crucial role in the process of 
carcinogenesis. The participation of oxidants seems to 
be the common factor to all these events
2,80,81
. It is 
clearly documented that inflammation and 
carcinogenesis are inter-related, numerous reports of 
cancer originating at sites of previous chronic 
inflammation are there in the literature
82
. Studies have 
been published on changes in morphology and in gene 
expression of mouse mammary epithelial cells after 
prolonged exposure to H2O2, which simulates chronic 
inflammation. In such oxidation conditions, a 
phenotypic cell conversion with similarities to 
malignant transformation was observed, including a 
fibroblastic morphology with intercellular spaces, 
implying a decrease in intercellular connections
83
.  
In the mechanisms of carcinogenesis and ageing along 
with ROS, various redox metals, due to their ability to 
generate free radicals, or non-redox metals, due to their 
ability to bind to critical thiols have been participated
84-90
. 
Iron-mediated oxidative stress is considered to be a 
principal cause of human colorectal cancer
80
. The 
second most important cause of lung cancer is 
occupational exposure to asbestos-containing about 








Chances for oxidative stress and cancer increased 
in occupational exposure to cadmium
87
. Directly 
cadmium is not capable of producing free radicals,  
but through indirect methods, it can cause free 
radical-induced damage the gene expression. 
Cadmium can cause activation of cellular protein 
kinases (protein kinase C), which results in enhanced 
phosphorylation of transcription factors and 
consequently lead to the transcriptional activation of 
target gene expression
90
. It has been suggested that 
cadmium can also be implicated in the pathogenesis 
of human pancreatic cancer and renal carcinomas. 
One of the potential lung carcinogen is Hexavalent 
chromium; Cr (VI)-induced cytotoxicity is associated 
with mitochondrial/lysosomal toxicity substantiated 
by the enhanced formation of free radicals
85
. 
Arsenic compounds are well established human 
carcinogens, which bind with SH groups and 
inhibiting various enzymes, including glutathione 
reductase
86
. Researchers agree with the hypothesis 
that arsenic may act as a co-carcinogennot by  
causing cancer directly, but by allowing other factors, 
such as cigarette smoke or UV radiation, to  
cause DNA mutations more effectively 
89,90
.  
The effect of arsenic on p53 is not completely 
understood. The experimental results show both p53 
dependent and p53 independent induction of 
apoptosis and also both, increased and decreased 
expression of the protein
90
. 
The oxidative DNA damage rate increased 35–50% 
by tobacco smoke, as estimated from the urinary 
excretion of 8-OH-G, or by 20–50%, estimated from 
the level of 8-OH-G in leukocytes
91
. The oxygen 
consumption, which is a main endogenous source of 
ROS, showed a close correlation with the 8-OH-G 
excretion rate, even though moderate exercise seems 
to have no current effect. Studies failed to show an 
influence on the oxidative DNA modification, by diet 
composition, including energy restriction and 
antioxidant supplements
92
. Along with ROS, reactive 
nitrogen species (RNS), such as peroxynitrites and 
nitrogen oxides have also been involved in DNA 
damage
93
. During reaction with guanine, peroxynitrite 
has been shown to form 8-nitroguanine. This adduct 
has the potential to induce G:C→T:A trans versions 
due to its structure. While the stability of this lesion in 
DNA is low, in RNA, however, this nitrogen adduct is 
stable. The potential connection between 8-nitro 
guanine and the process of carcinogenesis is under 
research. 
In cancer progression 
In the cancer cells ROS act as messengers in 
cellular signaling transduction pathways, promote 
cellular growth and proliferation, and finally 
contribute to cancer development
94,95
. ROS contribute 
to the uncontrolled cell proliferation and compromise 
the cellcycle regulatory function.Direct ROS 
interaction with specific receptors and modulation of 
the redox states of signaling molecules are the 
mechanisms responsible for stimulation of cell 
proliferation. Any alteration in the redox status of a 
signaling molecule may lead to stimulation of cell 
growth and cell proliferation. Oxidative modifications 
of redox-sensitive transcription factors may also be 
involved in ROS-mediated modulation of cell growth 
and cell survival
94,96,97
. Most important characteristics 
of tumor cells are their increased ability to survive 
compared with the normal cells. ROS are reported to 
be tumorigenic by virtue of their ability to increase 
cell proliferation, survival, and cellular migration. 
ROS can develop DNA damage, leading to genetic 
lesions that initiate the tumorogenicity and subsequent 
tumor progression. Simultaneously, ROS is also 
capable for cellular senescence, cell death and can 
therefore, function as anti-tumorigenic agents. ROS 
promote tumor cell survival or act as anti-tumorigenic 
agents completely depends on the cell and tissues, the 
location of ROS production and the concentration of 
individual ROS. 
The up-regulation of multiple intracellular 
signaling pathways, including cascades involved in 
survival, proliferation and cell cycleprogression are 
required for uncontrolled tumor cell proliferation.The 
noticeable effects of oxidants on signaling pathways 
have been observed in the MAPK/AP-1 and  
NF-κB pathways98. Cell division needs tremendous 
energy requirements therefore, the production of 
metabolites from the energy generating reactions  
must be buffered to prevent oxidative damage and 
ultimately cell death. Hence the induction of redox 




Oxygen radicals may overcome tumor invasion and 
metastasis by increasing the rates of cell migration. 
Before converting into invasive carcinoma, epithelial 
cells undergo profound alterations in morphology and 
adhesive mode, resulting in a loss of normal epithelial 
polarization and differentiation and a switch to a more 
motile, invasive phenotype. For example, treatment of 
mammalian carcinoma cells with hydrogen peroxide 




before intravenous injection into mice enhances lung 
metastasis formation, indicating that an important 
function for ROS is the seeding of metastatic tumor 
cells
100
. This might be due to a lesser attachment of 
tumor cells to the basal lamina or otherwise due to 
more activity or expression of proteins that regulate 
cellular motility. Oxidative stress regulates the 
expression of intercellular adhesion protein-1  
(ICAM-1), a cell surface protein in endothelial and 
epithelial cells, most likely because of the activation 
of NF-κB. ICAM-1 together with IL-8 regulates the 
trans endothelial migration of neutrophils and has a 
potential function in tumor metastasis
101
. 
An angiogenic response by the host blood vessels 
in solid tumors forms a new vascular network for the 
supply of nutrients and oxygen
102
. This neovascular 
response is partly responsible for tumor growth and 
metastatic spread
103,104
. Angiogenesis in tumors is 
regulated by the so-called ―angiogenic switch‖  
which allows the transition from low invasive and 
poorly vascularized tumors to highly invasive and 
angiogenic tumors. Tumor cells express a set of 
molecules that initiate tumor vascularization to 
increase further in size. 
Numerous cellular stress factors, including 
hypoxia, nutrient deprivation, and ROS are important 
stimuli of angiogenicsignaling
105
. Overexpression of 
RAS (rat sarcoma viral oncogene) has also been 
linked to vascularization of tumors
106
. Transformation 
by RAS stabilizes HIF-1α and up-regulates the 
transcription of vascular endothelial growth factor-A 
(VEGF-A). Chemical antioxidants inhibit the 
mitogenic activity of RAS, indicating that ROS 
participate directly in malignant transformation. ROS 
stabilize HIF-1α protein and induce production of 
angiogenic factors by tumor finally. 
 
In cancer treatment 
A state of oxidative stress is created in the body 
when cancer is treated using anticancer drugs and 
radiation. Active oxygen triggers apoptosis via p53 
and cytochrome release from mitochondria. Ionizing 
radiations-generates charged particles or electrons that 
carry the kinetic energy provided by photons (X rays, 
γ rays),falls directly on DNA producing breaks in 
phosphodiester bonds. This leads to around 30% of 
DNA damage
107,108
. The remaining damage is created 
by the action of free radicals. In a process known as 
water ―radiolysis‖ the •OH, which has high biological 
relevance, is generated by the interaction of ionizing 
radiation (e.g., X- or gamma rays) with the water 
molecule. The deposition of energy from radiation 
also leads to the formation of hydrogen atoms, 
hydrated electrons, and other molecular products. It 
includes molecular hydrogen, hydrogen peroxide, and 
peroxynitrite, compounds that generate DNA-damage 
like 8-hydroxyguanine (8-OH-Gua), 8-OH-dG,  
8-oxoguanine and consequently single and  
double-strand DNA breaks
109
. Free radicals are 
important factors in carcinogenesis
110,111. The •OH has 
an extraordinarily short life in the human body, due to 
collisions with the different and abundant molecules 
in the biological environment. Scientists have come to 
the conclusion that radiotherapy generates the •OH, 
which is the free radical most associated with  
cell death during the treatment of cancer. The  
NO• appears to act as radio sensitizer under conditions 
of hypoxia, mimickingthe effects of oxygen relating on 
radiation-induced DNA damage
112-114
. One of the major 
late complication after radiotherapy in breast cancer is 




For triggering apoptosis within the cell, 
chemotherapy mainly depending on ROS. 
Chemotherapy agents are divided into different categories 
like alkylating agents (e.g., cyclophosphamide, 
ifosfamide), anthracycline antibiotics which affect 
nucleic acids (e.g., doxorubicin, bleomycin), platinum 
compounds (e.g., cisplatin), mitotic inhibitors  
(e.g., vincristine), antimetabolites (e.g., 5-fluorouracil), 
camptothecin derivatives (e.g., topotecan), biological 
response modifiers (e.g., interferon) and hormone 
therapies (e.g., tamoxifen). Among chemotherapeutic 
agentsthe level of ROS generation is different
116
. 
Agents that produce high levels of ROS include 
anthracyclines, platinum coordination complexes, alkylating 
agents, epipodophyllotoxins and camptothecins
117
. 
Nucleoside and nucleotide analogs, antifolates, 
taxanes and vinca alkaloids produce only low levels 
of ROS. Formation of superoxide radicals during 
apoptosis induced by chemotherapeutic agents, 
involving the release of cytochrome c from 
mitochondria, NADH dehydrogenase and reduced 
coenzyme Q10 divert electrons from the electron 
transport system (ETS) to oxygen
117
. Anthracyclines 
develops the highest levels of ROS. They divert 
electrons from the ETS of cardiac mitochondria, 
resulting in the formation of superoxide radicals  
in addition to generating ROS at other cellular  
sites. Doxorubicin (Adriamycin), the most studied 




anthracycline, is one of the most effective 
chemotherapeutic agent used in several cancers
117
. 
The toxic effect of Doxorubicin is compared to its 
ability to react with cancer cell DNA. It can induce 
DNA damage, mainly through inhibition of DNA 
topoisomerase II enzyme after induction of  
double-strand DNA breaks resulting in covalent 
attachment between active site residues of 
topoisomerase II and 5 end of DNA. Doxorubicin 
also intercalates into DNA and alters helical torsion 
which also causes DNA damage. Its use is seriously 
limited by its acute and chronic toxic effects in the 
heart including cardiomyopathy and congestive heart 
failure
117-119
. Free radical generation and subsequent 
oxidative stress mediate its toxic effects. Studies 
showing that antioxidant supplementation in 
combination with Doxorubicin protects against 







Studies in head and neck and cervix carcinomas 
concluded that the pattern of a decreased level of 
antioxidants compared to the controls before 
radiotherapy, increasing oxidative stress during 
radiotherapy and again increased antioxidant level 
after radiotherapy is positively associated with 
survival in the patients
120,121
. 
The initial decrease in the antioxidant level of blood 
in carcinoma patients, compared to healthy control is 
due to the increased oxidative stress due to the tumor 
formation in the body. During treatment (radiotherapy 
and chemotherapy), administration of free radicals 
increase oxidative stress, the decline in the level of 
antioxidants may be due to both decreased dietary 
intake and increased utilization of antioxidants by  
free radicals produced from ionizing radiations.  
Studies reveal that increased oxidative stress is 
beneficial during therapy, it promotes the tumor cells 
destruction. In post radiotherapy, high level of 
antioxidants in blood was positively associated with  
the survival of the cancer patient. It directly indicates 
the recovery. Supplementation of antioxidants after 
treatment of malignancy may improve the outcome in 
patients. 
According to them, antioxidant supplementation 
decreases the oxidative stress level especially in regard 
to protein damage
122
. It maintains the hemoglobin level 
of the body, and improve the efficacy of radiotherapy 
by supplying enough oxygen to the tumor. Quality of 
life of this group is also improved. But the risk lies in 
the recurrence of the tumor after some period of time. 
Further long-term studies are required for authenticity. 
 
Controversial views of antioxidant use in cancer 
therapy  
Free radicals are used for the treatment of cancer in 
conventional therapies like chemotherapy and 
radiotherapy. The supplementation of antioxidants 
during the treatment always remains a matter of 
controversy. Since ROS plays a role in drug induced 
apoptosis, one might suspect that antioxidants may 
inhibit ROS and prevent apoptosis of cancer cells. 
There is an intense argument on the concurrent use of 
antioxidants with the conventional cancer treatments. 
Numerous patients have turned to such 
complementary treatments with antioxidants. Many 
oncologists have moved against antioxidants and 
warned their patients not to use them during 
conventional cancer therapy
123,124
. The base of this 
argument was on the fact that radiation therapy and 
some chemotherapy drugs generate ROS and 
antioxidants may prevent cancer cells to be killed by 
ROS. As a result, the parallel use of supplemental 
antioxidants should be avoided during conventional 
cancer treatment
125
. Not only in the scientific circles, 
but also in media as well this argument is still 
continuing
126
. Literature has been reviewed, in order 
to find the result if there is any interference between 
the concurrent use of antioxidants and conventional 
cancer therapy
127
. Except for three specific 
interferences (tangeretin with tamoxifen, NAC with 
doxorubicin and -carotene with 5-fluorouracil), 
considerable data exists demonstrating increased 
effectiveness as well as decreased side effects of 
chemotherapeutic agents when given with 
antioxidants
122
. There are situations in which 
antioxidant supplementation would be undesirable for 
cancer patients, but the issue is more complicated than 
indicated. Even though many chemotherapy drugs 
induce the formation of free radicals, their anticancer 
effects not only depend on free radicals. Antioxidant 
may enhance the effects of chemotherapy, while 
preventing free radical induced side effects. 
Considerable existing data show increased 
effectiveness of many chemotherapeutic agents, as 
well as a decrease in toxic adverse effects, when 
given concurrently with antioxidants
116,123,128-132
. 
Oxidative stress interferes with cellular processes 
that are necessary for antineoplastic agents to exert 
their optimal cytotoxicity on cancer cells. Modest 
levels of oxidative stress have been shown to reduce 




the cytotoxicity of anticancer drugs
117,127
. Thus, it was 
claimed that the formation of ROS that occurs when 
anticancer drugs are administered may diminish the 
effectiveness of the treatment
117,127,133
. In addition, 
since some side effects caused by antineoplastic 
agents appear to be prevented by certain antioxidants, 
administering these supplements during 
chemotherapy may diminish the development of side 
effects as well as improve the response to therapy
117
. 
Although limited clinical studies on the effect of 
antioxidants in cancer treatment are available. 
However, experimental studies showed that in cancer 
cells, antioxidant vitamins selectively induce 
apoptosis, prevent angiogenesis and metastatic spread, 
suggesting a potential role for antioxidants as 





Abundant knowledge of diverse mechanisms of 
oxidative stress involved in carcinogenesis and cancer 
therapies are available, but the current understanding 
is still not sufficient to cure cancer. The state of 
oxidative stress in carcinogenesis and tumor-bearing 
conditions is a complicated mechanism in which 
various complex interactions are involved. The 
deleterious effects of oxidative stress include injury to 
cells, induces gene mutation, involved in 
carcinogenesis by influencing intracellular signal 
transduction and transcription factors directly or 
indirectly via antioxidants. Research has been proven 
that free radicals can induce proliferation of cancer 
cells and protect them by increasing their adaptive 
response, thus leading to cancer progression and even 
metastatic diseases. Oxidative stress, a marker of 
tissue damage is found to increase with the 
progression of cancer. Oxidative stress can be 
measured by the levels of Lipid peroxidation, protein 
products and various antioxidants in the serum of 
cancer patients. Alternatively, free radicals are also 
recognized as the main mechanism of most of the 
conventional cancer therapies, leading cancer cells to 
apoptosis and hence to cancer regression. 
Antioxidants have also been shown to exhibit 
dichotomous effects when used as a supplement to 
cancer therapy. More research is needed for better 
understanding of the mechanisms and specific 
apoptotic pathways involved in ROS-induced cell 
death and to determine the most rational and effective 
combination of redox active agents. Further, it may 
reveal the missing mechanism of oxidative 
homeostasis in normal vs. malignant cells, and help 
understanding the role of antioxidants along with 
conventional therapies in an integrative, personalized 
medical fight against cancer.  
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